chevron_leftBack
As of 24 April 2025, SD Biosensor, Inc. has a market cap of $737.76M USD, ranking #9750 globally and #232 in South Korea. It ranks #943 in the Healthcare sector, and #85 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$737.76MUSD
1.06T KRW
Enterprise Value
$843.69MUSD
1.21T KRW
Revenue (TTM)
$483.87MUSD
694.57B KRW
EBITDA (TTM)
$60.76MUSD
87.22B KRW
Net Income (TTM)
-$68.56MUSD
-98.41B KRW
EBITDA Margin
13%
Profit Margin
-14%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
576
Founded
2010
Website
sdbiosensor.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | 2.1% | -5.6% | -20% | 1% | -8.9% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
137310
SD 바이오센서
ISIN: KR7137310009
Shares Out.:
Shares Outstanding:
117.813M1
Shares Float:
32.169M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.06K KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SD Biosensor, Inc.
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.
